Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases-a debate.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
    • Publication Information:
      Publication: 1997- : London : Oxford University Press
      Original Publication: London, New York, Academic Press.
    • Subject Terms:
    • References:
      Int J Antimicrob Agents. 2023 Mar;61(3):106718. (PMID: 36640851)
      Open Forum Infect Dis. 2022 Mar 04;9(6):ofac112. (PMID: 35611348)
      Med Mycol. 2021 Feb 04;59(2):206-209. (PMID: 32944777)
      Antimicrob Agents Chemother. 2017 Aug 24;61(9):. (PMID: 28630185)
      Med Mycol. 2017 Jul 1;55(5):528-534. (PMID: 27744310)
      Clin Infect Dis. 2021 Dec 6;73(11):e3647-e3655. (PMID: 32955088)
      Ann Intern Med. 2015 Jan 20;162(2):81-9. (PMID: 25599346)
      J Clin Microbiol. 2003 Aug;41(8):3623-6. (PMID: 12904365)
      Antimicrob Agents Chemother. 2001 Mar;45(3):857-69. (PMID: 11181372)
      J Fungi (Basel). 2022 Oct 25;8(11):. (PMID: 36354888)
      Int J Infect Dis. 2011 Dec;15(12):e874-81. (PMID: 22040924)
      Front Microbiol. 2018 Jul 25;9:1612. (PMID: 30090091)
      Lancet Microbe. 2022 Jun;3(6):e464-e470. (PMID: 35659908)
      Clin Infect Dis. 2004 Dec 1;39(11):1563-71. (PMID: 15578352)
      Clin Infect Dis. 2007 Jan 1;44(1):2-12. (PMID: 17143808)
      Infection. 2011 Jun;39(3):201-10. (PMID: 21512792)
      N Engl J Med. 2002 Aug 8;347(6):408-15. (PMID: 12167683)
      Antimicrob Agents Chemother. 2019 Dec 20;64(1):. (PMID: 31685475)
      Antimicrob Agents Chemother. 2023 May 17;67(5):e0141922. (PMID: 37022196)
      J Antimicrob Chemother. 2021 Dec 24;77(1):16-23. (PMID: 34508633)
      Clin Infect Dis. 2017 Jun 01;64(11):1557-1563. (PMID: 28472247)
      Clin Infect Dis. 2002 Jan 1;34(1):7-14. (PMID: 11731939)
      Clin Infect Dis. 2023 Jul 5;77(1):38-45. (PMID: 36905147)
      Int J Pharm. 2020 Nov 15;589:119813. (PMID: 32871218)
      Clin Infect Dis. 2008 Sep 1;47(5):674-83. (PMID: 18637757)
      Clin Microbiol Infect. 2020 Jun;26(6):784.e1-784.e5. (PMID: 31972317)
      Ann Intern Med. 2022 Sep;175(9):1298-1304. (PMID: 36037471)
      J Clin Microbiol. 2015 Sep;53(9):2832-7. (PMID: 26085618)
      J Clin Microbiol. 2012 Jul;50(7):2330-6. (PMID: 22553232)
      Antimicrob Agents Chemother. 2001 Sep;45(9):2635-7. (PMID: 11502542)
      Clin Microbiol Infect. 2016 Jun;22(6):562.e1-8. (PMID: 26899830)
      Drugs. 2021 Oct;81(15):1703-1729. (PMID: 34626339)
      Mycopathologia. 2007 Apr;163(4):191-202. (PMID: 17410480)
      JAMA Netw Open. 2021 May 3;4(5):e218348. (PMID: 34003274)
      Clin Infect Dis. 2015 Oct 15;61(8):1293-303. (PMID: 26113653)
      Lancet. 2021 Feb 6;397(10273):499-509. (PMID: 33549194)
      Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):166-173. (PMID: 29882160)
      J Fungi (Basel). 2023 Jan 17;9(2):. (PMID: 36836246)
      J Clin Med. 2020 Feb 24;9(2):. (PMID: 32102465)
      Lancet Infect Dis. 2016 Jul;16(7):828-837. (PMID: 26969258)
      Cancer. 2007 Jul 1;110(1):112-20. (PMID: 17525971)
      Lancet. 2016 Feb 20;387(10020):760-9. (PMID: 26684607)
      Clin Infect Dis. 2021 Oct 5;73(7):e1645-e1648. (PMID: 32887998)
      Transpl Infect Dis. 2021 Jun;23(3):e13547. (PMID: 33338319)
      J Fungi (Basel). 2017 Oct 18;3(4):. (PMID: 29371573)
    • Grant Information:
      Shionogi B.V., London, UK; F2G Ltd, Manchester, UK
    • Accession Number:
      0 (Antifungal Agents)
    • Publication Date:
      Date Created: 20240731 Date Completed: 20240731 Latest Revision: 20240822
    • Publication Date:
      20240822
    • Accession Number:
      PMC11334067
    • Accession Number:
      10.1093/jac/dkae158
    • Accession Number:
      39084680